Characteristics | With CNS involvement | Without CNS involvement | P value |
---|---|---|---|
N=14 | N=26 | ||
Age, median (range, year) | 44.0 (23.0-62.0) | 51.0(15-75) | .392 |
Gender, men, n(%) | 9 (34.6%) | 10(71.4%) | .046 |
B symptoms, n (%) | 10 (71.4%) | 15(57.7%) | .502 |
Elevated LDH, n (%) | 14 (100%) | 16(61.5%) | .007 |
Median WBC×109/l (range) | 17.2 (1.2-66.57) | 9.58(1.38-40.06) | .729 |
Median Hb, g/l (range) | 95.0 (61.0-145.0) | 100.5(45.0-141.0) | .777 |
Median PLT, ×109/l (range) | 73.5 (20.0-355.0) | 113.0(3.0-509.0) | .843 |
International Prognostic | .002 | ||
Index, n (%) | 0 | 9 (34.6%) | |
2 | 6 (42.9%) | 14(53.8%) | |
3 | 8 (57.1%) | 3(11.5%) | |
4-5 | .896 | ||
Treatment, n (%) | 4 (28.6%) | 10(38.5%) | |
CHOP/CHOP-like | 1 (7.1%) | 3(11.5%) | |
R- CHOP/CHOP-like | 4 (28.6%) | 5(19.2%) | |
Intensive regimes | 5 (35.7%) | 8(30.8%) |